Clinical Trial Update: Safety and Efficacy of OSTEOFORM (rhPTH [1-34]) in Increasing Bone Mineral Density in Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating OSTEOFORM (rhPTH [1-34]) for increasing bone mineral density in osteoporosis has completed with safety and efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• OSTEOFORM (rhPTH (1-34))

Snippet

Sponsor: Virchow Group | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED